Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Multimodality Aphasia Therapy Mmat

Research Leaders

9 sponsors active, led by University of Calgary

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Completed3
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Multimodality Aphasia Therapy Mmat2
  • 1hz Sham Rtms2
  • 1hz Inhibitory Rtms2
  • Lowintensity Physical Exercise1
  • Mobile Evidencebased Aphasia Therapy1

Active Sponsors

  • University of Calgary2
  • Hospital Universitari Joan XXIII de Tarragona.1
  • University of California, San Francisco1
  • Universitat Pompeu Fabra1
  • University of California, Berkeley1

Top Investigators

Related Conditions

  • Stroke2
  • Aphasia2
  • Aphasia Fluent2
  • Aphasia Acquired1
  • Aphasia Following Nontraumatic Intracerebral Hemorrhage1

Activity Timeline